Investigation of the Plasmodium falciparum RH5-Interacting Protein (PfRIPR) as a blood-stage malaria vaccine target von Williams, BG

Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region von Dye, C, Williams, BG

The scale and dynamics of COVID-19 epidemics across Europe von Dye, C, Cheng, RCH, Dagpunar, JS, Williams, BG

Monitoring trends in under-5 mortality rates through national birth history surveys. von Korenromp, E, Arnold, F, Williams, BG, Nahlen, B, Snow, R

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. von Korenromp, E, Williams, BG, Gouws, E, Dye, C, Snow, R

Impact of malaria control on childhood anaemia in Africa -- a quantitative review. von Korenromp, E, Armstrong-Schellenberg, JR, Williams, BG, Nahlen, B, Snow, R

Modelling challenges in context: lessons from malaria, HIV, and tuberculosis von Childs, L, Abuelezam, N, Dye, C, Gupta, S, Murray, M, Williams, BG, Buckee, C

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites von Weiss, GE, Ragotte, RJ, Quinkert, D, Lias, AM, Dans, MG, Boulet, C, Looker, O, Ventura, OD, Williams, BG, Crabb, BS, Draper, SJ, Gilson, PR

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex von Williams, BG, King, LDW, Pulido, D, Quinkert, D, Lias, AM, Silk, SE, Ragotte, RJ, Davies, H, Barrett, JR, McHugh, K, Rigby, CA, Alanine, DGW, Barfod, L, Shea, MW, Cowley, LA, Dabbs, RA, Pattinson, DJ, Douglas, AD, Lyth, OR, Illingworth, JJ, Jin, J, Carnrot, C, Kotraiah, V, Christen, JM, Skinner, K, Higgins, MK, Draper, SJ

Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies von Alanine, DGW, Quinkert, D, Kumarasingha, R, Mehmood, S, Donnellan, FR, Minkah, NK, Dadonaite, B, Diouf, A, Galaway, F, Silk, SE, Jamwal, A, Marshall, JM, Miura, K, Foquet, L, Elias, SC, Labbé, GM, Douglas, AD, Jin, J, Payne, RO, Illingworth, JJ, Pattinson, DJ, Pulido, D, Williams, BG, De Jongh, WA, Wright, GJ, Kappe, SHI, Robinson, CV, Long, CA, Crabb, BS, Gilson, PR, Higgins, MK, Draper, SJ

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies von King, LDW, Pulido, D, Barrett, JR, Davies, H, Quinkert, D, Lias, AM, Silk, SE, Pattinson, DJ, Diouf, A, Williams, BG, McHugh, K, Rodrigues, A, Rigby, CA, Strazza, V, Suurbaar, J, Rees-Spear, C, Dabbs, RA, Ishizuka, AS, Zhou, Y, Gupta, G, Jin, J, Li, Y, Carnrot, C, Minassian, AM, Campeotto, I, Fleishman, SJ, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Long, CA, Miura, K, Ashfield, R, Skinner, K, Howarth, MR, Biswas, S, Draper, SJ

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype von Barrett, JR, Pipini, D, Wright, ND, Cooper, AJR, Gorini, G, Quinkert, D, Lias, AM, Davies, H, Rigby, CA, Aleshnick, M, Williams, BG, Bradshaw, WJ, Paterson, NG, Martinson, T, Kirtley, P, Picard, L, Wiggins, CD, Donnellan, FR, King, LDW, Wang, LT, Popplewell, JF, Silk, SE, de Ruiter Swain, J, Skinner, K, Kotraiah, V, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Minassian, AM, Lauffenburger, DA, Miura, K, Long, CA, Wilder, BK, Koekemoer, L, Tan, J, Nielsen, CM, McHugh, K, Draper, SJ